173 related articles for article (PubMed ID: 23433775)
1. The anti-tumor efficiency of poly(L-glutamic acid) dendrimers with polyhedral oligomeric silsesquioxane cores.
Pu Y; Chang S; Yuan H; Wang G; He B; Gu Z
Biomaterials; 2013 May; 34(14):3658-66. PubMed ID: 23433775
[TBL] [Abstract][Full Text] [Related]
2. A novel poly(l-glutamic acid) dendrimer based drug delivery system with both pH-sensitive and targeting functions.
Yuan H; Luo K; Lai Y; Pu Y; He B; Wang G; Wu Y; Gu Z
Mol Pharm; 2010 Aug; 7(4):953-62. PubMed ID: 20481567
[TBL] [Abstract][Full Text] [Related]
3. A duplex oligodeoxynucleotide-dendrimer bioconjugate as a novel delivery vehicle for doxorubicin in in vivo cancer therapy.
Lee IH; Yu MK; Kim IH; Lee JH; Park TG; Jon S
J Control Release; 2011 Oct; 155(1):88-95. PubMed ID: 20854858
[TBL] [Abstract][Full Text] [Related]
4. Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs).
Chang Y; Meng X; Zhao Y; Li K; Zhao B; Zhu M; Li Y; Chen X; Wang J
J Colloid Interface Sci; 2011 Nov; 363(1):403-9. PubMed ID: 21821262
[TBL] [Abstract][Full Text] [Related]
5. Nanoscaled poly(L-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer.
Li M; Song W; Tang Z; Lv S; Lin L; Sun H; Li Q; Yang Y; Hong H; Chen X
ACS Appl Mater Interfaces; 2013 Mar; 5(5):1781-92. PubMed ID: 23410916
[TBL] [Abstract][Full Text] [Related]
6. Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy.
She W; Li N; Luo K; Guo C; Wang G; Geng Y; Gu Z
Biomaterials; 2013 Mar; 34(9):2252-64. PubMed ID: 23298778
[TBL] [Abstract][Full Text] [Related]
7. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
[TBL] [Abstract][Full Text] [Related]
8. Dendronized nanoconjugates of lysine and folate for treatment of cancer.
Jain K; Gupta U; Jain NK
Eur J Pharm Biopharm; 2014 Aug; 87(3):500-9. PubMed ID: 24698808
[TBL] [Abstract][Full Text] [Related]
9. The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy.
She W; Luo K; Zhang C; Wang G; Geng Y; Li L; He B; Gu Z
Biomaterials; 2013 Feb; 34(5):1613-23. PubMed ID: 23195490
[TBL] [Abstract][Full Text] [Related]
10. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
Wen S; Liu H; Cai H; Shen M; Shi X
Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549
[TBL] [Abstract][Full Text] [Related]
11. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
[TBL] [Abstract][Full Text] [Related]
12. Redox and pH-responsive poly (amidoamine) dendrimer-poly (ethylene glycol) conjugates with disulfide linkages for efficient intracellular drug release.
Hu W; Cheng L; Cheng L; Zheng M; Lei Q; Hu Z; Xu M; Qiu L; Chen D
Colloids Surf B Biointerfaces; 2014 Nov; 123():254-63. PubMed ID: 25277289
[TBL] [Abstract][Full Text] [Related]
13. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent.
Li N; Li N; Yi Q; Luo K; Guo C; Pan D; Gu Z
Biomaterials; 2014 Nov; 35(35):9529-45. PubMed ID: 25145854
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and gene delivery of poly-L-lysine octa(3-aminopropyl)silsesquioxane dendrimers: nanoglobular drug carriers with precisely defined molecular architectures.
Kaneshiro TL; Wang X; Lu ZR
Mol Pharm; 2007; 4(5):759-68. PubMed ID: 17705440
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
[TBL] [Abstract][Full Text] [Related]
17. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
18. Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties.
He X; Wu X; Cai X; Lin S; Xie M; Zhu X; Yan D
Langmuir; 2012 Aug; 28(32):11929-38. PubMed ID: 22799877
[TBL] [Abstract][Full Text] [Related]
19. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
[TBL] [Abstract][Full Text] [Related]
20. Poly(ethylene glycol)-modified PAMAM-Fe3O4-doxorubicin triads with the potential for improved therapeutic efficacy: generation-dependent increased drug loading and retention at neutral pH and increased release at acidic pH.
Nigam S; Chandra S; Newgreen DF; Bahadur D; Chen Q
Langmuir; 2014 Feb; 30(4):1004-11. PubMed ID: 24446987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]